{
 "drug": "Ceftazidime Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "11/14/2025",
 "dayN": 284,
 "cat": "Anti-Infective",
 "companies": [
  "Hospira, Inc., a Pfizer Company"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "11/14/2025",
   "update_type": "New",
   "initial_posting_date": "11/14/2025",
   "package_ndc": "0409-5093-11",
   "generic_name": "Ceftazidime Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA064032"
    ],
    "brand_name": [
     "TAZICEF"
    ],
    "generic_name": [
     "CEFTAZIDIME"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-5093",
     "0409-5092"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CEFTAZIDIME"
    ],
    "rxcui": [
     "1659283",
     "1659287",
     "1659292",
     "1659294"
    ],
    "spl_id": [
     "71a753fc-ae3d-4d94-bc72-a3a51a5bdd9a"
    ],
    "spl_set_id": [
     "9b73979c-c95a-4433-0a9d-f9cea3cb557f"
    ],
    "package_ndc": [
     "0409-5092-11",
     "0409-5092-16",
     "0409-5093-14",
     "0409-5093-11"
    ],
    "unii": [
     "9M416Z9QNR"
    ]
   },
   "update_date": "11/14/2025",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Tazicef, Injection, 2 g (NDC 0409-5093-11)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "11/14/2025",
   "update_type": "New",
   "initial_posting_date": "11/14/2025",
   "package_ndc": "0409-5092-16",
   "generic_name": "Ceftazidime Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "11/14/2025",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Tazicef, Injection, 1 g (NDC 0409-5092-16)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "To Be Discontinued"
  }
 ]
}